Icon Cancer Centre Singapore offers a comprehensive and holistic approach to cancer care, supporting patients through every stage of their journey, from diagnosis and treatment to life beyond cancer. They are the only oncology provider in Singapore to receive ACHSI accreditation, demonstrating their commitment to safety and quality benchmarked against international standards. The center adopts a patient-centered approach, combining Singaporean and Australian practices to understand and meet the unique needs of each individual.
Icon Cancer Centre provides a wide array of treatments and support services, including:
The center emphasizes providing information and support, with resources available for patients and their families and carers. They also offer guidance on navigating life after cancer treatment.
MBBS (AUS), MRCP (UK), FRCP (Glasg), MMed (Int Med), FAM
Dr. Karmen Wong is a medical oncologist with over 30 years of clinical experience. She received her oncology training at the National University Hospital (NUH), the National Cancer Centre Singapore (NCC), and the University of California, San Francisco (UCSF) through an HMDP scholarship.
A pioneer in her field, Dr. Wong helped establish Singapore’s first multi-disciplinary breast cancer treatment program at NCC two decades ago, creating a collaborative approach to cancer care. She also initiated the bone marrow transplant program for solid tumors at Singapore General Hospital (SGH) in 1997. Her contributions to oncology earned her an award for oral presentation at SGH’s 9th Annual Scientific Meeting in 1988.
Dr. Wong is actively involved in cancer research as a co-investigator in numerous clinical trials focusing on new cancer treatments. Notably, she participated in the CompLEEment-1 trial study, with findings presented at major conferences like ASCO 2019 and ESMO 2018. Her dedication to advancing cancer treatment extends to fostering a strong cancer support network for her patients.
In 1999, she presented the first Asian study on patients’ attitudes toward breast cancer treatment at the Annual Meeting of the American Society of Clinical Oncology. She has also published numerous peer-reviewed articles, authored textbook chapters, and frequently delivers lectures across ASEAN on the latest advancements in cancer care.
Dr. Wong welcomes referrals for all cancer types, with a particular interest in breast, gastrointestinal, and gynecological cancers.
Senior Consultant, Specialist in Medical Oncology, MBBS, M Med (Int Med), MRCP (UK), FAMS
Dr. Elizabeth Au is a medical oncologist specializing in breast, gynaecological, gastrointestinal, and lung cancers. She received prestigious scholarships from the Public Service Commission and Ministry of Health, and completed advanced medical training, including a fellowship at the Mayo Clinic where she was quickly promoted to Senior Clinical Fellow.
She played a key role in developing medical oncology in Singapore, serving as the first head of Cancer Education at the National Cancer Centre and helping establish its oncology department. Dr. Au has led clinical trials contributing to the approval of new chemotherapy drugs and has published her research in leading medical journals.
She is a fellow of the Academy of Medicine Singapore and an active member of both local and international oncology societies. Dr. Au is fluent in English, Mandarin, Malay, Cantonese, and Teochew.
Senior Consultant in Paediatrics & Paediatric Haematology-Oncology BSc (USA) MD (USA) MPH (Singapore) Board Certified, Paediatrics & Paediatric Haematology-Oncology (USA)
Dr. LeLe Aung is a highly experienced Paediatrician and Paediatric Haematologist-Oncologist with over 20 years of clinical practice. She holds a BSc in Biology and an MD from U.S. institutions, and completed her training in General Paediatrics and a Fellowship in Paediatric Haematology-Oncology at prestigious medical centers in the U.S. She is board-certified in both fields and accredited in Singapore.
Based in Singapore since 2006, Dr. Aung specializes in holistic, evidence-based care for children with complex solid tumours. She has published research on childhood cancers such as osteosarcoma and neuroblastoma and actively contributes to medical education through various teaching roles.
Senior Consultant, Specialist in Medical Oncology MBBS (Hons), MRCP (UK), FAMS (Medical Oncology), FRCP (UK)
Dr. Daniel Chan is a highly accomplished medical oncologist who graduated with honours from NUS School of Medicine in 2000. He earned his MRCP (UK) in 2004 and completed specialist training in medical oncology at the National University Cancer Institute of Singapore. He further advanced his expertise in the U.S. at UCLA and Cedars-Sinai Medical Centre, training under renowned oncologists and conducting research under Professor Phillip Koeffler with support from prestigious fellowships.
On returning to Singapore, he served as a consultant oncologist and director of undergraduate education at NUS. He was also involved in cancer research, particularly on triple negative breast cancer, supported by a National Medical Research Council grant. Notably, he was the first in South Asia to use the PD-1 inhibitor immunotherapy drug in clinical practice in 2014.
Dr. Chan treats all cancer types, with special interest in breast, colon, lung cancers, lymphoma, and sarcoma. He is multilingual, fluent in English, Mandarin, Bahasa Melayu, Bahasa Indonesia, and Hokkien.
Senior Consultant in Radiation Oncology, Palliative Medicine MBBS (Spore), EU MSc of Rad Biol (distinction) (UCL,UK), FRCR (Clinical Oncology) (UK) Palliative Medicine Radiation Oncologist
Dr. Francis Chin is a highly experienced Radiation Oncologist with a strong background in both radiation and medical oncology. He is a recipient of prestigious ASEAN and Chevening scholarships and was the first Asian student to complete an EU-sponsored MSc in Radiation Biology with distinction.
Dr. Chin spent over 20 years at the National Cancer Center in Singapore and is currently a visiting consultant at KK Women and Children’s Hospital. He holds several leadership roles, including Deputy Chair of SingHealth’s Institutional Research Boards, member of the Clinical Risk Management Committee, and lead investigator for a $10 million proton therapy grant.
He has held academic roles at SingHealth Duke-NUS and led multiple quality improvement and radiation proton development projects. Internationally recognized, his work has been featured by the IAEA, and he was president-elect of the South East Asian Radiation Oncology Group (SEAROG). He also contributed to the Oxford *Textbook of Critical Care* as a chapter author.
Dr. Chin treats a wide range of cancers, with particular expertise in breast, gynecological, gastrointestinal, prostate, pediatric cancers, and soft tissue sarcomas. He is multilingual, fluent in English, Mandarin, Malay, Hokkien, and Cantonese.
Senior Consultant, Specialist in Radiation Oncology MBChB (UK), MRCP (UK), FRCR (UK), FAMS
Dr. Choo Bok Ai is a Senior Radiation Oncologist in private practice with over 22 years of experience, specializing in radiation therapy for various cancers including breast, gynecological, head and neck, lung, prostate, skin, and sarcoma. He is proficient in advanced radiation techniques like SRT, SBRT, IMRT, IGRT, VMAT, and brachytherapy, and was the first in Singapore to perform MRI-guided brachytherapy for cervical cancer. He also co-holds a patent related to cervical cancer genetics.
He holds multiple prestigious qualifications, including MRCP (UK), FRCR (UK), and fellowship with the Academy of Medicine Singapore. He has held academic and leadership roles, including Assistant Professor at NUS and Chairman of the Chapter of Radiation Oncology.
Dr. Choo is a published researcher with over 30 journal articles and involvement in 13 clinical trials. He is active in advocacy and support roles, currently serving as Vice President and Program Director at Breast Cancer Foundation Singapore and committee member of the Singapore Cancer Society.
He also founded the Dream Maker program to fulfill terminal wishes for cancer patients and received the Healthcare Humanity Award in 2018 for his contributions to cancer care. Dr. Choo is multilingual and frequently featured in local media.
Senior Consultant, Specialist in Medical Oncology. Medical Director, Icon Cancer Centre at Mt Alvernia MBBS (UK), FRACP (Australia), MPhil (Sydney)
Dr. Patricia Kho is a seasoned medical oncologist with over 20 years of experience, currently practicing at Mount Elizabeth Novena, Gleneagles, and Mount Alvernia Hospital in Singapore. She specializes in lung, head and neck, breast, and gastrointestinal cancers. Dr. Kho earned her medical degree from the University of Newcastle upon Tyne, UK, and trained in medical oncology at the Sydney Cancer Centre under prominent mentors. She holds a fellowship from the Royal Australasian College of Physicians (FRACP).
Her research interests focus on personalized cancer treatments, and she completed a Master of Philosophy (Medicine) from the University of Sydney with a thesis on colorectal cancer treatment. She has held several leadership roles in Sydney, including Head of Medical Oncology at Liverpool Hospital and Director of its Clinical Trials unit. Dr. Kho is multilingual, fluent in English, Mandarin, Hokkien, and Cantonese.
Specialist in Medical Oncology MBBS, MMed (Int Med), MRCP (UK), FAMS (Med Onc), FRCP (UK), MBA (MIT)
Prof Kong Hwai Loong is an Adjunct Associate Professor at the National University of Singapore (NUS) and a visiting specialist in Medical Oncology at NUHS. He formerly held leadership roles at A*STAR, including Executive Director of BMRC and Deputy Managing Director.
He holds a medical degree from NUS, is a specialist in Medical Oncology, and has an MBA from MIT. He completed his postgraduate training at New York Hospital – Cornell Medical Centre. Prof Kong has earned numerous accolades, including the ASCO Merit Award, Singapore Young Scientist Award, and the National Day Award for contributions to research.
Beyond medicine, he is active in education and governance, serving in various professional and advisory roles. He specializes in treating adult solid tumours, particularly breast, gastrointestinal, lung, and urological cancers, and is committed to mentoring future healthcare professionals.
Prof Kong is multilingual, fluent in several Chinese dialects, English, Malay, and has basic Japanese, enabling him to communicate with a diverse range of patients.
Senior Consultant, Specialist in Medical Oncology BSc, MBBS, MRCP, MMed
Dr. Lee Guek Eng is a medical oncologist who graduated from the National University of Singapore with degrees in Medicine and Surgery, and a Bachelor of Science (Hons) in Cell and Molecular Biology. She trained and practiced at the National Cancer Centre Singapore for ten years, focusing on general oncology with a special interest in female cancers, particularly breast and gynaecological cancers.
Dr. Lee has been actively involved in both local and international cancer research, especially in breast cancer affecting young women. She received a prestigious NMRC fellowship in 2016 to train at the Dana-Farber Cancer Institute in the U.S., where she specialized in breast cancer in young women and pregnancy-associated cases. She later helped develop a dedicated program in Singapore to support and educate this patient group.
Additionally, she received a second NMRC grant for research into treatments for brain metastases in advanced breast cancer. Dr. Lee has represented Singapore at many international oncology conferences and frequently presented her research. She now practices in the private sector, accepts all cancer referrals, and is fluent in English, Mandarin, Teochew, and Cantonese.
Senior Consultant, Specialist in Medical Oncology MChB, ABIM (Int Med), ABIM (Med Onc), ABIM (Heme), FRCP (Edin)
Dr. Robert Lim is a medical doctor who graduated from the University of St Andrews and the University of Edinburgh. He completed postgraduate training in Internal Medicine, Haematology, and Medical Oncology in New York at Cornell and Memorial Sloan Kettering. He holds American Board certifications in these specialties and is a Fellow of the Royal College of Physicians in Edinburgh.
Since returning to Singapore in 1998, Dr. Lim has specialized in cancers of the gastrointestinal tract, including colorectal, gastric, liver, pancreatic, biliary tract, and esophageal cancers. He has contributed to influential research in colon and pancreatic cancer and served as Head of Haematology-Oncology at the National University Cancer Institute, Singapore (2005–2011).
Dr. Lim is actively involved in medical training, mentorship, and clinical leadership, having held key roles including Associate Director at NCIS and council member at Dover Park Hospice. He is fluent in English and Mandarin.
Clinical Haematologist MBBS (HK), FRCP (Edin), FRCP (Glasg), FAMS
Dr. Ng is a haematologist who graduated with distinction from Hong Kong University in 1969. He has held academic and clinical roles in Hong Kong, London, and New York, including as a Senior Research Fellow at Memorial Sloan Kettering Cancer Center. Since 1984, he has been in private practice at Mt Elizabeth Hospital in Singapore and served as Chairman of its Medical Advisory Board from 1993 to 1995. He has contributed to national medical research and ethics review boards and is active in medical mediation and education. Dr. Ng has published in leading haematology journals and specializes in treating anaemia, clotting and bleeding disorders, deep vein thrombosis, and thrombocytopenia.
Specialist in Medical Oncology MBBS, FRCP (Canada), FACP (USA), FRACP (Aus), FRCP (Edin), FRCP (Glasg), FAMS (Medical Oncology), Diplomate of American Board of Internal Medicine, Haematology and Medical Oncology
Dr Tan Yew Oo is a prominent figure in Singapore’s medical community, having served as Professor of Medicine at NUS and Chief of Medicine at NUH. He played a key role in establishing Medical Oncology at NUH and was a tenured faculty member at NUS from 1978 to 1993. Despite managing a busy private practice, he remains actively involved in healthcare and education, serving on several national medical committees, including those under SingHealth and the Ministry of Health.
He was the founding Chairman of the Medical Board at Farrer Park Hospital and received the Public Service Medal in 2020 for his contributions to public service and healthcare. In 2021, the Tan Yew Oo Professorship in Pathology was established at Duke-NUS in his honor.
Dr Tan has published extensively, speaks at international conferences, and participates in clinical trials. He accepts referrals for all cancer types, with a focus on breast, gastrointestinal, liver, lung cancers, and lymphoma. He is multilingual, fluent in English, Mandarin, Hokkien, and Malay.
Senior Consultant, Specialist in Medical Oncology BSc (USA), MD (USA), Internal Medicine (USA), Medical Oncology (USA), Diplomate Internal Medicine and Medical Oncology ABIM (USA)
Dr. Hsieh Wen-Son is a cancer specialist focused on developing new diagnostics and targeted treatments. A Rhodes Scholar, he studied Philosophy and Psychology at Oxford and earned his medical degree from Johns Hopkins University. He trained in Internal Medicine at Duke and Medical Oncology at Johns Hopkins, later joining its faculty in haematologic malignancies. He is currently a part-time Assistant Professor at Johns Hopkins and a Principal Associate at Singapore’s Cancer Sciences Institute.
Dr. Hsieh’s research centers on targeted therapies, immunotherapy, and molecular diagnostics. He leads international studies across Asia and the U.S. on treatments for lymphomas, nasopharyngeal, and liver cancers, and has been principal investigator in over 30 clinical trials. He has published 80+ scientific works and frequently speaks at conferences. Clinically, he treats all cancer types, with a focus on lymphoma, head and neck, lung, and hepatobiliary cancers. He speaks English and Mandarin.
Medical Oncology MBBS (UK), MRCP (UK), FRCP (UK), FACP (USA), Diplomate American Board of Internal Medicine and Medical Oncology
Dr. Whang Hwee Yong is a specialist in medical oncology with extensive training and experience, including at the Royal Marsden Hospital in London and MD Anderson Cancer Center in Houston, where she later became an Associate Professor. She is a Member of the Royal College of Physicians (UK), a Diplomate of the American Board of Internal Medicine, and a Fellow of the American College of Physicians.
She has been actively involved in cancer research, particularly in developmental therapeutics and the treatment of breast cancer, brain tumors, and CNS metastases, with over 60 peer-reviewed publications. Her research and presentations have been featured at major oncology conferences such as ASCO and AACR.
Dr. Whang’s clinical interests include chemotherapy, clinical pharmacology, and cancers of the breast, liver, and central nervous system. She maintains a broad oncology practice, with a focus on solid tumors including breast, gynecological, and hepatic cancers.
Senior Consultant, Specialist in Medical Oncology MBBS, FRACP (Aus), FAMS (Medical Oncology)
Dr. Yeap Heng Oon is a medical oncologist with over a decade of clinical experience. He earned his medical degree from the University of Sydney, receiving academic honors including the Faculty of Science International Merit Scholarship and membership in the Golden Key International Honour Society. He completed his oncology training at Crown Princess Mary Cancer Centre and pursued a clinical research fellowship at Sydney West Clinical Trials Centre, focusing on breast, urogenital cancers, novel cancer therapies, and pharmacogenomics.
He has presented and published his research internationally, including in the Journal of Clinical Oncology. From 2011 to 2015, he worked as a consultant oncologist at Johns Hopkins Singapore and Tan Tock Seng Hospital, where he led the oncology clinic and multiple clinical trials.
Dr. Yeap is a fellow of the Royal Australasian College of Physicians and the Academy of Medicine Singapore and has been involved with prominent oncology societies. He emphasizes holistic, compassionate cancer care and specializes in breast, gastrointestinal, lung, melanoma, and urogenital cancers. He is fluent in English, Mandarin, and Hokkien.
Specialist Sphere is a platform that connects patients with trusted medical specialists, providing easy access to expert care and empowering informed
healthcare decisions.
Connecting You with Expert Specialists for Every Need.
Copyright © All rights reserved | Optimized by Sotavento Medios
